Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Non Operating Income (2019 - 2025)

Biodesix (BDSX) has disclosed Non Operating Income for 7 consecutive years, with -$4.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non Operating Income rose 51.09% year-over-year to -$4.1 million, compared with a TTM value of -$7.4 million through Dec 2025, up 43.77%, and an annual FY2025 reading of -$7.4 million, up 12.34% over the prior year.
  • Non Operating Income was -$4.1 million for Q4 2025 at Biodesix, down from $409000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $1.6 million in Q3 2021 and bottomed at -$8.4 million in Q4 2024.
  • Average Non Operating Income over 5 years is -$2.4 million, with a median of -$2.4 million recorded in 2023.
  • The sharpest move saw Non Operating Income skyrocketed 160.51% in 2021, then crashed 415.09% in 2022.
  • Year by year, Non Operating Income stood at -$1.6 million in 2021, then plummeted by 302.25% to -$6.4 million in 2022, then soared by 64.81% to -$2.3 million in 2023, then tumbled by 268.27% to -$8.4 million in 2024, then surged by 51.09% to -$4.1 million in 2025.
  • Business Quant data shows Non Operating Income for BDSX at -$4.1 million in Q4 2025, $409000.0 in Q3 2025, and -$3.8 million in Q2 2025.